FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mariann Harangi

Research Profile

Chemicals & Drugs

Concepts & Ideas

Risk Factors

Procedures

Physiology

Phenotype

Disorders

Co-author Network

Publications

TOP 3
Mariann Harangi; Lilla Juhász; Noémi Zsíros; György Paragh
[Statin-induced adverse effects -- facts and genes].
Sándor Somodi; Orsolya Szilágyi; András Balajthy; Mariann Harangi; György Panyi; György Paragh; Zoltán Pethő; Péter Hajdu
Analysis of the K+ current in human CD4+ T lymphocytes in hypercholesterolemic state.
Ferenc Sztanek; Lajos Lőcsey; György J R Paragh; Ildikó Seres; László Asztalos; Mariann Harangi; János Padra; György Paragh
Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mariann Harangi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mariann Harangi; Lilla Juhász; Noémi Zsíros; György Paragh
[Statin-induced adverse effects -- facts and genes].
Orvosi hetilap 2013;154(3):83-92.
2013: Sándor Somodi; Orsolya Szilágyi; András Balajthy; Mariann Harangi; György Panyi; György Paragh; Zoltán Pethő; Péter Hajdu
Analysis of the K+ current in human CD4+ T lymphocytes in hypercholesterolemic state.
Cellular immunology 2013;281(1):20-6.
2012: Ferenc Sztanek; Lajos Lőcsey; György J R Paragh; Ildikó Seres; László Asztalos; Mariann Harangi; János Padra; György Paragh
Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(7):2866-72.
2012: Ferenc Sztanek; Ildikó Seres; Mariann Harangi; Péter Koncsos; Lajos Lőcsey; György Paragh
Effect of nutritional status on human paraoxonase-1 activity in patients with chronic kidney disease.
Kidney & blood pressure research 2012;36(1):310-9.
2012: Éva Varga; Ildikó Seres; Ferenc Sztanek; Mariann Harangi; István Kárpáti; Péter Koncsos; György Paragh
Low high-density lipoprotein cholesterol is not responsible for decreased paraoxonase activity in chronic renal failure.
Kidney & blood pressure research 2012;35(4):265-72.
2011: Péter Koncsos; Endre V Nagy; Dénes Páll; Laszlo Bajnok; Mariann Harangi; Lajos Józsa; Ildikó Seres; György Paragh
Favorable effect of short-term lifestyle intervention on human paraoxonase-1 activity and adipokine levels in childhood obesity.
Journal of the American College of Nutrition 2011;30(5):333-9.
2011: Mariann Harangi; Tibor Kovács; László Mikó; Éva Rákóczi; László Rejto; Gabriella Szucs; László Tóth; László Galuska; György Paragh
Malignancy or inflammation? A case report of a young man with fever of unknown origin.
Pathology oncology research : POR 2011;17(2):409-13.
2010: Mariann Harangi; István Balogh; János Harangi; György Paragh
[Genetic background of the efficacy of cholesterol absorption. The role of Niemann-Pick C1-like 1 receptor and its genetic variations in lipid metabolism].
Orvosi hetilap 2010;151(34):1376-83.
2010: Antónia Szántó; Mariann Harangi; Ildikó Seres; György Paragh; Margit Zeher
Decreased human paraoxonase-1 activity in patients with Sjögren's syndrome.
International immunology 2010;22(7):605-9.
2010: Peter Szodoray; Gabor Papp; Britt Nakken; Mariann Harangi; Margit Zeher
The molecular and clinical rationale of extracorporeal photochemotherapy in autoimmune diseases, malignancies and transplantation.
Autoimmunity reviews 2010;9(6):459-64.
2010: Péter Koncsos; Ildikó Seres; Mariann Harangi; István Illyés; Lajos Józsa; Ferenc Gönczi; László Bajnok; György Paragh
Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels.
Pediatric research 2010;67(3):309-13.
2010: Ildikó Seres; László Bajnok; Mariann Harangi; Ferenc Sztanek; Peter Koncsos; György Paragh
Alteration of PON1 activity in adult and childhood obesity and its relation to adipokine levels.
Advances in experimental medicine and biology 2010;660():129-42.
2009: Mariann Harangi; Ildikó Seres; János Harangi; György Paragh
Benefits and difficulties in measuring HDL subfractions and human paraoxonase-1 activity during statin treatment.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2009;23(6):501-10.
2009: Mariann Harangi; Hossein Z Mirdamadi; Ildikó Seres; Ferenc Sztanek; Miklós Molnár; Andrea Kassai; Zoltán Derdák; László Illyés; György Paragh
Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.
Translational research : the journal of laboratory and clinical medicine 2009;153(4):190-8.
2009: György Paragh; Ildikó Seres; Mariann Harangi; Zsuzsa Pocsai; László Asztalos; Lajos Locsey; Gyorgy Szeles; László Kardos; Eva Varga; Istvan Karpati; Roza Adany
Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease.
Nephron. Clinical practice 2009;113(1):c46-53.
2009: Eva Varga; Ildikó Seres; Mariann Harangi; Ferenc Sztanek; László Asztalos; Lajos Lõcsey; Béla Borbás; János Szegedi; István Kárpáti; György Paragh
Serum cystatin C is a determinant of paraoxonase activity in hemodialyzed and renal transplanted patients.
Disease markers 2009;26(3):141-8.
2008: Hossein Z Mirdamadi; Ferenc Sztanek; Zoltan Derdak; Ildikó Seres; Mariann Harangi; György Paragh
The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters.
British journal of clinical pharmacology 2008;66(3):366-74.
2008: György Paragh; Mariann Harangi; Márk László
[New trends in lipidology: the increasing role of HDL-cholesterol].
Orvosi hetilap 2008;149(30):1395-404.
2008: Mariann Harangi; Ildikó Seres; Mária Tünde Magyar; Istvan Csipo; Sándor Sipka; Attila Valikovics; László Csiba; Dániel Bereczki; György Paragh
Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease.
Cerebrovascular diseases (Basel, Switzerland) 2008;25(1-2):122-8.
2007: Mária Audikovszky; Gyula Pados; Ildikó Seres; Mariann Harangi; Péter Fülöp; Eva Katona; László Illyés; Gábor Winkler; Eva M Katona; György Paragh
Orlistat increases serum paraoxonase activity in obese patients.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2007;17(4):268-73.
2007: Mariann Harangi; János Mátyus; Erzsébet Nagy; Emöke Nagy; György Paragh; József Balla; Anna V Oláh
Identification of sulfhemoglobinemia after surgical polypectomy.
Clinical toxicology (Philadelphia, Pa.) 2007;45(2):189-92.
2006: György Paragh; Ildikó Seres; Mariann Harangi; Annamária Erdei; Mária Audikovszky; Lóránd Debreczeni; Anna Kovácsay; László Illyés; Gyula Pados
Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.
British journal of clinical pharmacology 2006;61(6):694-701.
2006: György Paragh; Mariann Harangi
[Treatment of dyslipidemia in clinical practice].
Orvosi hetilap 2006;147(9):389-94.
2006: Mariann Harangi; Tamás Köbling; György Paragh
[The role of transmembrane lipidtransporter molecules in the atherosclerotic process].
Orvosi hetilap 2006;147(6):251-7.
2005: Zoltán Szabó; Mariann Harangi; István Lörincz; Ildikó Seres; Eva Katona; Zsolt Karányi; György Paragh
Effect of hyperlipidemia on QT dispersion in patients without ischemic heart disease.
The Canadian journal of cardiology 2005;21(10):847-50.
2005: Mariann Harangi; Wolfgang E Kaminski; Martin Fleck; Evelyn Orsó; Margit Zeher; Emese Kiss; Zoltán Szekanecz; Erika Zilahi; Jörg Marienhagen; Charalampos Aslanidis; György Paragh; Anne Isine Bolstad; Roland Jonsson; Gerd Schmitz
Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjögren's syndrome.
European journal of immunology 2005;35(1):305-17.
2004: Mariann Harangi; Ildikó Seres; Zsuzsa Varga; Gabriella Emri; Zoltán Szilvássy; György Paragh; Eva Remenyik
Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage.
European journal of clinical pharmacology 2004;60(10):685-91.
2004: György Paragh; D Törocsik; Ildikó Seres; Mariann Harangi; László Illyés; Zoltán Balogh; Péter Kovács
Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia.
Current medical research and opinion 2004;20(8):1321-7.
2003: György Paragh; Ildikó Seres; Mariann Harangi; Zoltán Balogh; László Illyés; Judit Boda; Zoltán Szilvássy; Péter Kovács
The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease.
Diabetes & metabolism 2003;29(6):613-8.
2002: Mariann Harangi; Charalampos Aslanidis; György Paragh; Gerd Schmitz
High-speed detection of the two common paraoxonase polymorphisms Leu55-->Met and Gln192-->Arg by real-time fluorescence PCR and melting curves.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2002;40(4):337-40.
2002: Mariann Harangi; Eva Remenyik E; Ildikó Seres; Zsuzsa Varga; Eva Katona; György Paragh
Determination of DNA damage induced by oxidative stress in hyperlipidemic patients.
Mutation research 2002;513(1-2):17-25.
2001: Mária Audikovszky; Gyula Pados; Ildikó Seres; Mariann Harangi; Péter Fülöp; Eva Katona; Gábor Winkler; György Paragh
[Changes in lipid profile and paraoxonase activity in obese patients as a result of orlistat treatment].
Orvosi hetilap 2001;142(50):2779-83.
2001: Zoltán Balogh; Ildikó Seres; Mariann Harangi; Péter Kovács; György Kakuk; György Paragh
Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
Diabetes & metabolism 2001;27(5 Pt 1):604-10.
2001: György Paragh; Mariann Harangi
[The role of HDL in the prevention of cardiovascular events].
Orvosi hetilap 2001;142(3):121-6.
1999: György Paragh; László Asztalos; Ildikó Seres; Zoltán Balogh; L Löcsey; István Kárpáti; János Mátyus; Eva Katona; Mariann Harangi; György Kakuk
Serum paraoxonase activity changes in uremic and kidney-transplanted patients.
Nephron 1999;83(2):126-31.